+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
RNA Editing Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
RNA Editing Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
New

RNA Editing Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 185 Pages
  • November 2025
  • Region: Global
  • TechSci Research
  • ID: 5952935
Free Webex Call
10% Free customization
Description Jump to:

Messenger RNA Modification is the fastest growing segment, North America is the largest regional market

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Global RNA Editing Technologies Market, valued at USD 262.28 Million in 2024, is projected to experience a CAGR of 7.16% to reach USD 397.16 Million by 2030. RNA editing technologies involve molecular processes that precisely modify specific nucleotide sequences within an RNA molecule after its transcription, distinct from permanent alterations to the genomic DNA. This enables targeted corrections of genetic mutations and modulation of gene expression for therapeutic, research, and diagnostic applications. The market's expansion is fundamentally driven by the increasing demand for precision medicine, significant advancements in CRISPR-based RNA editing tools, and growing investments in RNA editing research.

Key Market Drivers

The global RNA editing technologies market is profoundly influenced by two pivotal factors: significant advancements in RNA editing technologies and the increasing demand for precision and personalized medicine. Ongoing innovation in advanced gene editing platforms, particularly CRISPR-based systems and enhanced delivery mechanisms, continues to broaden the therapeutic applicability of RNA editing. For instance, according to the Innovative Genomics Institute, in March 2024, the UK's Medicines and Healthcare Products Regulatory Agency approved Casgevy for sickle cell disease and transfusion-dependent beta-thalassemia in November 2023, with subsequent FDA approval for sickle cell disease in December 2023, marking the first regulatory clearances for a CRISPR-based therapy.

Key Market Challenges

The technical complexity associated with efficient delivery and precise targeting systems for RNA editing components within specific cells and tissues represents a significant impediment to market expansion. This challenge directly affects the progression and success of therapeutic development by prolonging research and development timelines and escalating costs. The difficulty in developing safe and effective methods to introduce RNA editing tools precisely into target cells, without off-target effects or degradation, limits the scalability and broad application of these advanced therapies.

Key Market Trends

Increased cross-sectoral collaborations and partnerships are significantly driving growth in the Global RNA Editing Technologies Market by fostering shared expertise and resources. These alliances between biotechnology firms, pharmaceutical companies, and academic institutions accelerate the complex research and development cycle of RNA editing solutions. For example, in September 2024, Prime Medicine announced a strategic research collaboration and license agreement with Bristol Myers Squibb, which included a $55 million upfront payment and a $55 million equity investment, to develop ex vivo T-cell therapies using Prime Editing technology, demonstrating significant financial commitment to such joint ventures.

Key Market Players Profiled:

  • ProQR Therapeutics NV
  • Sirna Therapeutics, Inc.
  • Shape Therapeutics, Inc.
  • Korro Bio, Inc.
  • Beam Therapeutics, Inc.
  • QIAGEN N.V.
  • UniQure NV (UniQure)
  • LAVA Therapeutics N.V.
  • argenx SE
  • Arrowhead Pharmaceuticals, Inc.

Report Scope:

In this report, the Global RNA Editing Technologies Market has been segmented into the following categories:

By Type of RNA:

  • Messenger RNA Modification
  • Transfer RNA Modification
  • Ribosomal RNA Modification

By Application:

  • Cancer
  • Genetic Disorders
  • Temporary Maladies

By Technique:

  • Insertion/Deletion
  • Deamination

By Region:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global RNA Editing Technologies Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global RNA Editing Technologies Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type of RNA (Messenger RNA Modification, Transfer RNA Modification, Ribosomal RNA Modification)
5.2.2. By Application (Cancer, Genetic Disorders, Temporary Maladies)
5.2.3. By Technique (Insertion/Deletion, Deamination)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America RNA Editing Technologies Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type of RNA
6.2.2. By Application
6.2.3. By Technique
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States RNA Editing Technologies Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type of RNA
6.3.1.2.2. By Application
6.3.1.2.3. By Technique
6.3.2. Canada RNA Editing Technologies Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type of RNA
6.3.2.2.2. By Application
6.3.2.2.3. By Technique
6.3.3. Mexico RNA Editing Technologies Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type of RNA
6.3.3.2.2. By Application
6.3.3.2.3. By Technique
7. Europe RNA Editing Technologies Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type of RNA
7.2.2. By Application
7.2.3. By Technique
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany RNA Editing Technologies Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type of RNA
7.3.1.2.2. By Application
7.3.1.2.3. By Technique
7.3.2. France RNA Editing Technologies Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type of RNA
7.3.2.2.2. By Application
7.3.2.2.3. By Technique
7.3.3. United Kingdom RNA Editing Technologies Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type of RNA
7.3.3.2.2. By Application
7.3.3.2.3. By Technique
7.3.4. Italy RNA Editing Technologies Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type of RNA
7.3.4.2.2. By Application
7.3.4.2.3. By Technique
7.3.5. Spain RNA Editing Technologies Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type of RNA
7.3.5.2.2. By Application
7.3.5.2.3. By Technique
8. Asia-Pacific RNA Editing Technologies Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type of RNA
8.2.2. By Application
8.2.3. By Technique
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China RNA Editing Technologies Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type of RNA
8.3.1.2.2. By Application
8.3.1.2.3. By Technique
8.3.2. India RNA Editing Technologies Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type of RNA
8.3.2.2.2. By Application
8.3.2.2.3. By Technique
8.3.3. Japan RNA Editing Technologies Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type of RNA
8.3.3.2.2. By Application
8.3.3.2.3. By Technique
8.3.4. South Korea RNA Editing Technologies Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type of RNA
8.3.4.2.2. By Application
8.3.4.2.3. By Technique
8.3.5. Australia RNA Editing Technologies Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type of RNA
8.3.5.2.2. By Application
8.3.5.2.3. By Technique
9. Middle East & Africa RNA Editing Technologies Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type of RNA
9.2.2. By Application
9.2.3. By Technique
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia RNA Editing Technologies Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type of RNA
9.3.1.2.2. By Application
9.3.1.2.3. By Technique
9.3.2. UAE RNA Editing Technologies Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type of RNA
9.3.2.2.2. By Application
9.3.2.2.3. By Technique
9.3.3. South Africa RNA Editing Technologies Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type of RNA
9.3.3.2.2. By Application
9.3.3.2.3. By Technique
10. South America RNA Editing Technologies Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type of RNA
10.2.2. By Application
10.2.3. By Technique
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil RNA Editing Technologies Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type of RNA
10.3.1.2.2. By Application
10.3.1.2.3. By Technique
10.3.2. Colombia RNA Editing Technologies Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type of RNA
10.3.2.2.2. By Application
10.3.2.2.3. By Technique
10.3.3. Argentina RNA Editing Technologies Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type of RNA
10.3.3.2.2. By Application
10.3.3.2.3. By Technique
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global RNA Editing Technologies Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. ProQR Therapeutics NV
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Sirna Therapeutics, Inc.
15.3. Shape Therapeutics, Inc.
15.4. Korro Bio, Inc.
15.5. Beam Therapeutics, Inc.
15.6. QIAGEN N.V.
15.7. UniQure NV (UniQure)
15.8. LAVA Therapeutics N.V.
15.9. argenx SE
15.10. Arrowhead Pharmaceuticals, Inc.
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

The companies profiled in this RNA Editing Technologies market report include:
  • ProQR Therapeutics NV
  • Sirna Therapeutics, Inc.
  • Shape Therapeutics, Inc.
  • Korro Bio, Inc.
  • Beam Therapeutics, Inc.
  • QIAGEN N.V.
  • UniQure NV (UniQure)
  • LAVA Therapeutics N.V.
  • argenx SE
  • Arrowhead Pharmaceuticals, Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedNovember 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 262.28 Million
Forecasted Market Value ( USD ) by 2030 $ 397.16 Million
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Ribonucleic Acid (RNA) Editing Market Report 2025 - Product Image

Ribonucleic Acid (RNA) Editing Market Report 2025

  • Report
  • 250 Pages
  • Global
From
gRNA - Global Strategic Business Report - Product Image

gRNA - Global Strategic Business Report

  • Report
  • 475 Pages
  • Global
From
RNA-based Therapeutics - Global Strategic Business Report - Product Image

RNA-based Therapeutics - Global Strategic Business Report

  • Report
  • 274 Pages
  • Global
From
Base Editing Market Size, Share & Trends Analysis Report by Products & Services (Platform, gRNA Design), by Application (Drug Discovery & Development), by Type, by End Use, by Region, and Segment Forecasts, 2025-2033 - Product Image

Base Editing Market Size, Share & Trends Analysis Report by Products & Services (Platform, gRNA Design), by Application (Drug Discovery & Development), by Type, by End Use, by Region, and Segment Forecasts, 2025-2033

  • Report
  • 120 Pages
  • Global
From
RNA Sequencing Market - Forecasts from 2025 to 2030 - Product Image

RNA Sequencing Market - Forecasts from 2025 to 2030

  • Report
  • 145 Pages
  • Global
From

About the RNA Editing Technologies Market

RNA editing technologies form an advanced sector within genomics, focused on the post-transcriptional modification of RNA molecules. Such technologies enable the alteration of nucleotide sequences within an RNA molecule, thereby modulating gene expression without altering the underlying DNA. RNA editing has applications in both basic research, where it is used to understand gene function and RNA metabolism, and in therapeutic development, which harnesses the technology to correct or modulate RNA transcripts involved in disease processes. The approach can circumvent some complexities inherent in direct DNA editing and offers a potentially reversible and transient method for gene modulation, which can be advantageous in a therapeutic context. Moreover, RNA editing holds promise for personalized medicine, as it can be tailored to address individual genetic mutations that lead to disease. Several companies are at the forefront of the RNA editing industry, tapping into this promising avenue of genomic medicine. Key players include Beam Therapeutics, which leverages base editing technology for precise RNA changes, and Editas Medicine, known for its CRISPR-based RNA editing platforms. Wave Life Sciences is another notable entity utilizing stereochemistry technology to enhance the effectiveness of RNA-based therapies. Lastly, ProQR Therapeutics is actively developing RNA therapies for the treatment of genetic disorders, specializing in ophthalmology and dermatology. These companies are part of a growing industry dedicated to exploring the potential of RNA editing to address a variety of genetic conditions and diseases. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.